News
July 2007
Lein files new patents
In July 2007 Lein filed three new patents covering innovative ways to align optical instruments to the eye. Developed in-house, and wholly owned by Lein, the technologies behind these patents have underpinned a marked improvement in the resolution of Lein’s measurements.
Graeme Clark said "During the course of clinical testing it became clear that ensuring that the meter was correctly aligned to the eye was fundamental to obtaining consistent results. The strength of these patents is not only that they protect our glucose measurement technology but also that they offer benefits in many other areas, in particular for the optometry market."
June 2007
Seven Spires Follows Investment in Lein
As a result of the quality of the clinical results obtained with Lein’s new prototypes Seven Spires has followed its initial investment in Lein with a further round of funding. Ed McCabe of Seven Spires said "Lein has advanced its technology significantly since our first investment and I am particularly excited about the opportunities their platform technology offers to expand into new areas alongside diabetes care."
April 2007
Lein successfully completes SEEDA funded project
In May 2006 Lein Applied Diagnostics was delighted to be awarded a Grant for Research and Development by the South East England Development Agency (SEEDA). This project ran until April 2007 and enabled Lein to develop a new generation prototype. This new meter has many improvements over the previous generation system and gives strong correlations to conventional finger stick meters.
"The support from SEEDA has enabled us to move forwards further than we expected" said Dan Daly. "Our new meter is capable of very impressive glucose measurements and is providing such high accuracy biometrics on the eye that we see many new market opportunities for the technology."
September 2006
Peter Woodford appointed as non-executive director
Lein is proud to announce the appointment of Peter Woodford as non-executive director. Peter has a great depth of experience of the diabetes care business. Following a period as Managing Director of Boehringer Mannheim/Roche Diagnostics UK, he served as Senior Vice President, Roche Diabetes Care, responsible firstly for the Europe, Middle East and Africa Region and latterly for Global Marketing, Strategy and Business Development leading all global strategic and commercial activities for Roche Diabetes Care, a £1.2 billion business and market leader in the diabetes monitoring segment. He also has broad experience as a board member of several private and publicly held companies. Dan Daly said "Peter is an excellent addition to our board, complementing the skills and experience of the other non-executive directors, Roy Johnson and Ian Page. Lein is rapidly developing beyond the start-up stage and the depth and level of experience now residing in the board reflects the maturing nature of the company".
Volunteers
If you have either Type I or Type II diabetes and would like to find out more about Lein's tests we would be keen to hear from you. We need volunteers to spend a few hours with us so that we can monitor changes in blood glucose levels with a finger stick test and compare these with the results obtained from laboratory measurements.
Please contact Dan Daly for more information.